Madison Avenue Partners, LP Quant / Systematic

CIK: 0001801265 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value ($000): $619,858 (100.0% shares, 0.0% debt)

Holdings (18)

GHC GRAHAM HLDGS CO 26.1%

Value ($000) $161,763 Shares 210,717 Est. Cost $495.40 Unrealized +42.0%

SN SHARKNINJA INC 18.2%

Value ($000) $112,573 Shares 1,807,237 Est. Cost $36.57 Unrealized +44.7%

TBPH THERAVANCE BIOPHARMA INC 10.1%

Value ($000) $62,900 Shares 7,012,226 Est. Cost $10.48 Unrealized -11.6%

WLY WILEY JOHN & SONS INC 8.4%

Value ($000) $52,115 Shares 1,366,771 Est. Cost $31.91 Unrealized 0.0%

— HESS CORP 7.4%

Value ($000) $45,833 Shares 300,270 Est. Cost $144.16 Unrealized —

STGW STAGWELL INC 7.2%

Value ($000) $44,458 Shares 7,147,662 Est. Cost $6.94 Unrealized -9.8%

GMED GLOBUS MED INC 6.1%

Value ($000) $37,724 Shares 703,276 Est. Cost $53.76 Unrealized 0.0%

NNI NELNET INC 4.4%

Value ($000) $27,469 Shares 290,213 Est. Cost $87.89 Unrealized 0.0%

MCHB HOMESTREET INC 2.2%

Value ($000) $13,621 Shares 905,022 Est. Cost $13.73 Unrealized 0.0%

— 2SEVENTY BIO INC 2.1%

Value ($000) $13,018 Shares 2,433,222 Est. Cost $4.36 Unrealized —

OVID OVID THERAPEUTICS INC 1.8%

Value ($000) $11,128 Shares 3,648,509 Est. Cost $2.19 Unrealized +52.6%

ONL ORION GROUP HLDGS INC 1.5%

Value ($000) $9,191 Shares 2,618,529 Est. Cost $179.40 Unrealized —

FSP FRANKLIN STR PPTYS CORP 1.2%

Value ($000) $7,472 Shares 3,291,443 Est. Cost $2.37 Unrealized —

— MERRIMACK PHARMACEUTICALS INC 0.9%

Value ($000) $5,719 Shares 387,221 Est. Cost $12.29 Unrealized —

GOSS GOSSAMER BIO INC 0.8%

Value ($000) $4,886 Shares 4,140,773 Est. Cost $1.15 Unrealized -4.5%

— CENTRAL & EASTERN EUROPE FD 0.6%

Value ($000) $4,025 Shares 422,823 Est. Cost $8.86 Unrealized —

— INDIVIOR PLC 0.6%

Value ($000) $3,489 Shares 162,895 Est. Cost $20.61 Unrealized —

ATMU ATMUS FILTRATION TECHNOLOGIES INC 0.4%

Value ($000) $2,475 Shares 76,732 Est. Cost $23.72 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
GHC	GRAHAM HLDGS CO	210,717	$161,763	26.1%	$495.40	+42.0%	COM CL B	384637104
SN	SHARKNINJA INC	1,807,237	$112,573	18.2%	$36.57	+44.7%	COM SHS	G8068L108
TBPH	THERAVANCE BIOPHARMA INC	7,012,226	$62,900	10.1%	$10.48	-11.6%	COM	G8807B106
WLY	WILEY JOHN & SONS INC	1,366,771	$52,115	8.4%	$31.91	0.0%	CL A	968223206
—	HESS CORP	300,270	$45,833	7.4%	$144.16	—	COM	42809H107
STGW	STAGWELL INC	7,147,662	$44,458	7.2%	$6.94	-9.8%	COM CL A	85256A109
GMED	GLOBUS MED INC	703,276	$37,724	6.1%	$53.76	0.0%	CL A	379577208
NNI	NELNET INC	290,213	$27,469	4.4%	$87.89	0.0%	CL A	64031N108
MCHB	HOMESTREET INC	905,022	$13,621	2.2%	$13.73	0.0%	COM	43785V102
—	2SEVENTY BIO INC	2,433,222	$13,018	2.1%	$4.36	—	COMMON STOCK	901384107
OVID	OVID THERAPEUTICS INC	3,648,509	$11,128	1.8%	$2.19	+52.6%	COM	690469101
ONL	ORION GROUP HLDGS INC	2,618,529	$9,191	1.5%	$179.40	—	COM	68629Y103
FSP	FRANKLIN STR PPTYS CORP	3,291,443	$7,472	1.2%	$2.37	—	COM	35471R106
—	MERRIMACK PHARMACEUTICALS INC	387,221	$5,719	0.9%	$12.29	—	COM NEW	590328209
GOSS	GOSSAMER BIO INC	4,140,773	$4,886	0.8%	$1.15	-4.5%	COM	38341P102
—	CENTRAL & EASTERN EUROPE FD	422,823	$4,025	0.6%	$8.86	—	COM	153436100
—	INDIVIOR PLC	162,895	$3,489	0.6%	$20.61	—	ORD	G4766E116
ATMU	ATMUS FILTRATION TECHNOLOGIES INC	76,732	$2,475	0.4%	$23.72	0.0%	COM	04956D107